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Background. Recent studies in mice have suggested that T cell immunity may be protective against pneu-
mococcal infection.
Methods. CD4 T cell proliferative responses to the pneumococcal proteins pneumolysin (Ply), Ply toxoid
(F433), and choline-binding protein A were investigated in peripheral blood mononuclear cells (PBMCs) and
adenoidal mononuclear cells (MNCs) obtained from children undergoing adenoidectomy.
Results. Ply and F433 induce significant proliferation of CD4 T cells in both PBMCs and adenoidal MNCs,
and both memory and naive phenotypes of CD4 T cells proliferated after stimulation. In PBMCs, CD4 T cell
proliferation induced by Ply and F433, which was associated with increased production of interferon (IFN)–g and
tumor necrosis factor (TNF)–a, was significantly lower in children who were culture positive for pneumococcus
than in those who were culture negative for pneumococcus ( ). Between groups, no such difference wasP ! .05
observed in adenoidal MNC CD4 T cell proliferation, which was associated with production of IFN-g and inter-
leukin (IL)–10. The CD4 T cell proliferation induced by Ply and F433 was inhibited by antibodies to Toll-like
receptor 4.
Conclusion. These data suggest that Ply induces CD4 T cell proliferative responses with production of IFN-
g and TNF-a in PBMCs or of IFN-g and IL-10 in adenoidal MNCs, which may be important in modulating
pneumococcal carriage in children.
Streptococcus pneumoniae (pneumococcus) causes com-
munity-acquired meningitis, septicemia, pneumonia,
and otitis media in children [1]. Pneumococcal carriage
precedes pneumococcal disease and is the source of
horizontal transmission [2]. The effectiveness of poly-
Received 15 September 2006; accepted 15 November 2006; electronically
published 6 March 2007.
Potential conflicts of interest: none reported.
Presented in part: 5th International Symposium on Pneumococci and Pneu-
mococcal Diseases, Alice Springs, Australia, 2–6 April 2006 (abstract SY.11-03);
16th European Congress of Immunology, Paris, France, 6–9 September 2006 (ab-
stract PD1854).
Financial support: The North Bristol National Health Service Trust Research
Foundation (grant RF172); SPARKS (Sport Aiding Medical Research for Kids) (grant
05BTL02).
Reprints or correspondence: Dr. Qibo Zhang, Dept. of Cellular & Molecular
Medicine, School of Medical Sciences, University of Bristol, University Walk,
Bristol, BS8 1TD UK (q.zhang@bristol.ac.uk).
The Journal of Infectious Diseases 2007; 195:1194–202
 2007 by the Infectious Diseases Society of America. All rights reserved.
0022-1899/2007/19508-0018$15.00
DOI: 10.1086/512617
saccharide and protein-conjugated polysaccharide vac-
cines is limited by their poor immunogenicity in young
children and by limited serotype coverage and non-
vaccine serotype replacement, respectively [3]. Recent
efforts have been made to find alternative protein an-
tigen vaccine candidates, including pneumolysin (Ply)
and choline-binding protein A (CbpA) [4, 5], because
they have the potential to induce protection in all age
groups and against most serotypes of pneumococcus.
Pneumococcus is considered to be an extracellular
bacterium against which antibody responses can play
a major role in protection against colonization, mucosal
infection, and invasive disease. Vaccine-induced anti-
capsular antibodies protect against both invasive disease
and colonization in humans [6–8]. However, naturally
acquired immunity in unimmunized children, which is
associated with progressive reduction in rates of inva-
sive disease and carriage from 2 years of age onward,
is unlikely to be caused by antipolysaccharide antibod-
CD4 T Cell Immunity to Pneumococci • JID 2007:195 (15 April) • 1195
ies alone, because the protection can occur before the devel-
opment of measurable systemic anticapsular antibodies [9]. We
recently noted that serum antibody levels to Ply and CbpA were
higher in children with no detectable pneumococcal carriage
than in children who were culture positive for pneumococcus,
suggesting that these antibodies are associated with protection
against carriage [10]. However, recent studies in mice have
suggested that T cell immunity may also provide an antibody-
independent protection against pneumococcal colonization
[11, 12]. Other evidence supporting a role for CD4 T cell im-
munity against pneumococcal infection includes the observa-
tion that major histocompatibility complex II–deficient mice,
which are deficient in CD4 T cells, are more susceptible to
pneumococcal pneumonia and septicemia [13] and that in-
duction of CD4 T cell migration and activation by pneumococci
is important for the development of early protective immunity
against infection [13].
To investigate whether there is an additional or comple-
mentary role for CD4 T cell activation by Ply and CbpA in the
development of protection against pneumococcal colonization
in humans, we investigated T cell proliferative responses and
cytokine production to Ply and CbpA in peripheral blood
mononuculear cells (PBMCs) and adenoidal mononuclear cells
(MNCs) in relation to nasopharyngeal carriage in children.
MATERIALS AND METHODS
Subjects and samples. Peripheral blood and adenoid tissue
samples were obtained from otherwise healthy children aged
3–10 years (median age, 5 years) who were undergoing ad-
enoidectomy for adenoidal hypertrophy at either Bristol Royal
Hospital for Children or Southmead Hospital in Bristol, United
Kingdom. Criteria for exclusion from the study included pre-
vious immunization against pneumococcus, receipt of antibi-
otics or steroids within 2 weeks of surgery, and the presence
of an immunodeficiency or any serious infection. Nasopha-
ryngeal swab specimens were obtained on the day that the
operation was performed, and they were cultured for pneu-
mococcus as described elsewhere [10]. In brief, swabs were
placed in tubes containing skim milk–tryptone-glucose-glycerin
broth, and they were stored at 70C until bacterial culture
was performed by inoculating 50 mL of the broth onto a blood
agar plate by use of a standard inoculating technique [14]. After
incubation was performed overnight at 37C (in an atmosphere
of 5% CO2), pneumococcal colonies were identified on the basis
of typical morphologic findings, a-hemolysis, and subculture
with optochin disk testing. The pneumococcal load was assessed
semiquantitatively by grading growth density on a scale from
+ to ++++, as described elsewhere [14]. The study was ap-
proved by the South Bristol local research ethics committee,
and written, informed consent was obtained from all subjects.
Protein antigens. Recombinant Ply, a Ply toxoid (F433),
and recombinant CbpA proteins were used as antigen stimu-
lants. The 3 proteins were expressed in and purified from Esch-
erichia coli expressing the respective genes [15, 16]. The original
source of each of the genes was the encapsulated type 2 pneu-
mococcal strain D39. F433 is a detoxified mutant of Ply with
a Trp433-Phe mutation, which reduces cytolytic activity but
retains antigenicity [17]. Purified tetanus toxoid (National In-
stitute for Biological Standards and Control) was used as a
positive control for antigen stimulation. The endotoxin levels
of the recombinant proteins were !0.01 IU/mg of protein, as
determined by limulus assay (BioWhittaker). An optimal dos-
age for each protein was chosen for stimulation at which no
detectable cell toxicity was observed, by use of both trypan blue
staining and/or flow cytometric analysis after propidium iodide
staining (data not shown).
Cell isolation and culture. Adenoids were processed, and
MNCs were isolated according to methods described elsewhere
[10, 18]. PBMCs were also isolated using Ficoll (Amersham
Biosciences) according to the manufacturer’s instructions. Cells
were washed in PBS and were resuspended at cells/mL64 10
in RPMI 1640 culture medium containing 2 mmol/L glutamine,
100 U/mL penicillin, and 100 mg/mL streptomycin, as well as
10% fetal bovine serum (FBS; Sigma). Cells were cultured in
96-well culture plates (Corning). In some experiments, cell cul-
ture supernatants were collected and stored at70C until they
were assayed for cytokines.
Depletion of T cell subsets from adenoidal MNCs. In some
experiments, cellular depletion of CD45RO+ (i.e., memory phe-
notype) cells from adenoidal MNCs was performed using mag-
netic cell sorting (MACS) according to the manufacturer’s in-
structions, before cells were cultured with stimulants. This
procedure was not performed for PBMCs, because there gen-
erally were not enough cells available from patients’ blood sam-
ples to allow for both experiments to be performed using un-
depleted and depleted cells. In brief, adenoidal MNCs were
washed in PBS with 1% bovine serum albumin (PBS/BSA) and
were incubated with anti-human CD45RO microbeads (Mil-
tenyi Biotec) at 4C for 15 min. The cells were washed and
passed through a column on a magnetic cell separator. The
CD45RO+ cell–depleted MNCs were collected and resuspended
in PBS/BSA. Depletion consistently yielded RO cells that were
199% pure (data not shown).
Analysis of cellular proliferation. Carboxyfluorescein di-
acetate 5,6 succinimidyl ester (CFSE; Molecular Probes) was
used to label adenoidal MNCs or PBMCs before culture, al-
lowing for tracking of cell division. In brief, cells stained with
CFSE (5 mmol/L) in PBS were incubated at 37C for 8 min,
followed by the addition of cold culture medium to quench
the reaction. The labeled cells were cultured with or without
antigen for a predetermined period. In some experiments, cells
were preincubated with blocking antibodies to Toll-like receptor
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(TLR)–2, TLR4, or isotype controls (eBioscience) at 37C for
1 h before antigen stimulation. Staining of cells with CD mark-
ers (e.g., CD4–phycoerythrin) was followed by flow cytometric
analysis. The “proliferation index” of CD4 T cells in adenoidal
MNCs or PBMCs was calculated as the percentage of prolif-
erated CD4 T cells—that is, lymphocytes (defined by forward/
side light scatter properties) expressing CD4 whose CFSE (FL1)
fluorescence was below a threshold above which all unstimu-
lated cells (at day 0) fluoresced after CFSE staining.
Flow cytometric analysis. Cells were suspended in 100 mL
of PBS and were incubated with phycoerythrin- or fluorescein
isothiocyanate–labeled anti-human CD3, CD4, CD8, CD45RA,
or RO (BD Biosciences) at 4C for 30 min in the dark. After
staining, cells were washed and resuspended in PBS with or
without propidium iodide and then were subjected to flow cy-
tometric analysis (FACScan; BD Biosciences). Flow cytometric
data were analyzed using WinMDI (The Scripps Institute).
Measurement of cytokines. Cell culture supernatants (on
day 3 after stimulation) were collected and assayed for inter-
leukin (IL)–2, IL-4, IL-5, IL-10, tumor necrosis factor (TNF)–
a, and interferon (IFN)–g by cytometric bead array (BD Bio-
sciences), according to the manufacturer’s instructions. The
intra-assay and interassay coefficients of variance were 5%
and !10%, respectively, for all the cytokines.
Statistical analysis. The significance of differences between
culture-positive and -negative subjects was analyzed using Stu-
dent’s t test. The general linear model of analysis of variance
(ANOVA) was used to analyze the effects of age and carriage
status on cellular proliferation. Associations between CD4 T
cell proliferation and bacterial load or antibody levels were
analyzed by Spearman’s or Pearson’s correlation test. The sig-
nificance of differences between stimulated and unstimulated
cell samples in a specified group of subjects was analyzed using
paired Student’s t test. Analysis was performed using SPSS soft-
ware (version 11.5; SPSS).
RESULTS
Patients’ demographic data and CD4 T cell subsets in ade-
noidal MNCs and PBMCs. A total of 38 patients were re-
cruited into the study, and pneumococcal carriage rates were
assessed by pneumococcal culture of nasopharyngeal swabs. No
difference was found in carriage rates between males ( )np 18
and females ( ) (33% and 30%, respectively). As in anp 20
previous study [10], younger children (age, 3–4 years [np
; 46%]) tended to have higher carriage rates than older chil-11
dren (age, 5–6 years [ ; 29%] and 7–10 years [ ;np 14 np 13
23%]). CD4+CD45RO+ T cells (memory phenotype) predom-
inated in adenoidal MNCs (57%–65% of all CD4+ T cells), and
CD4+CD45RA+ T cells (naive phenotype) predominated in
PBMCs (78%–89% of all CD4+ T cells). No differences were
shown between the percentages of CD4 T cells in culture-pos-
itive and culture-negative patients (data not shown).
CD4 T cell proliferation induced by Ply and CbpA. Pro-
liferation of CD4 T cells was observed in both adenoidal MNCs
and PBMCs after stimulation with Ply, the toxoid F433, and
CbpA (figure 1A). These responses were dose dependent (figure
1B). At concentrations 10.1 mg/mL (for Ply) and 1 mg/mL (for
F433), there were decreases in proliferation associated with cy-
tolytic effects, as confirmed by propidium iodide staining and
flow cytometric analysis (data not shown). The pro-proliferative
effects of Ply, F433, and CbpA were abrogated by prior treat-
ment with proteinase K followed by boiling, but not by coin-
cubation with polymyxin B (data not shown).
CD4 T cell proliferation induced by Ply in both memory
and naive phenotypes. To determine whether the proliferated
CD4 T cells originate from memory or naive phenotypes, cel-
lular depletion of CD45RO+ cells from adenoidal MNCs was
performed. Ply and F433 induced significant proliferative re-
sponses (detectable at day 4) in undepleted adenoidal MNCs
and weaker cellular proliferative responses (detectable from day
6) in MNCs that contained naive T (RO) cells only (figure
2A and 2B). Figure 2C shows the CD4 T cell proliferation in
naive (RO) cells, compared with a stronger response noted in
undepleted MNCs (containing memory T cells), at day 8 after
stimulation. Although CbpA induced CD4 T cell proliferation
in undepleted MNCs, no significant proliferation was shown
in CD45RO (naive phenotype) cells.
Association of CD4 T cell proliferation and nasopharyngeal
carriage. To investigate whether there is any association be-
tween CD4 T cell immunity and current nasal carriage, CD4
T cell proliferation was compared between children with de-
tectable nasal colonization and those without such colonization.
Figure 3A shows that the CD4 T cell proliferation indices in
PBMCs after stimulation with Ply or F433 were significantly
higher in children who were culture negative than in those who
were culture positive for pneumococci. Among culture-positive
patients, there was a statistically significant inverse relationship
between CD4 T cell proliferation indices and pneumococcal
density in culture ( ; ). This effect of carriagerp0.64 P ! .05
status on CD4 proliferation was independent of age ( ,P ! .05
general linear model of ANOVA). No such difference was found
after CbpA stimulation. In contrast, in adenoidal MNCs, there
was no such difference between culture-negative and -positive
children in CD4 T cell proliferation after either Ply, F433, or
CbpA stimulation (figure 3B). However, when memory T cells
were depleted from adenoidal MNCs, a higher CD4 T cell
proliferation index was shown in the RO cells from culture-
negative patients than in the RO cells from patients who were
culture positive after stimulation with Ply or F433 as seen in
PBMCs (figure 3C). There were no differences in CD4 T cell
proliferation in either PBMCs or adenoidal MNCs after stim-
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Figure 1. A, Cellular proliferation analyzed by carboxyfluorescein diacetate 5,6 succinimidyl ester (CFSE) at day 7 (when cell proliferation became
significant for all responding subjects and on the linear part of the proliferative curve [see figure 2A]) after stimulation with recombinant protein
antigens (pneumolysin [Ply], 0.05 mg/mL; Ply toxoid [F433], 0.5 mg/mL; and choline-binding protein A [CbpA], 1 mg/mL). Fluorescence-activated cell
sorter dot plots show percentages of proliferated CD4 T cells in adenoidal mononuclear cells (Ad MNCs) (top) and peripheral blood mononuclear cells
(PBMCs) (bottom). B, Dose-response curve of CD4 T cellular proliferation upon stimulation by Ply (circles), F433 (squares), and CbpA (triangles) at day
7 in Ad MNCs (black symbols) and PBMCs (white symbols). Both panels show representative data from 1 of 6 experiments.
ulation with tetanus toxoid between culture-negative and cul-
ture-positive children (figure 3A–3C).
IFN-g and TNF-a production associated with CD4 T cell
proliferation in PBMCs. To identify the cytokines associat-
ed with Ply-induced T cell proliferation and with protection
against carriage, concentrations of IL-2, IL-4, IL-5, IL-10, TNF-
a, and IFN-g were measured in cell culture supernatants after
antigen stimulation and were compared with such concentra-
tions in unstimulated controls. In PBMCs, production of IFN-
g and TNF-a was shown to be associated with CD4 T cell
proliferation after stimulation with Ply (figure 4A and 4B).
Similar associations were also shown after F433 stimulation
( and for IFN-g and TNF-a, respectively;rp 0.69 rp 0.71
). The concentrations of IFN-g and TNF-a in cell cultureP ! .05
supernatants at day 3 were higher in patients who were culture
negative for pneumococcus than in patients who were culture
positive for pneumococcus after stimulation by Ply and F433
(figure 4C). For the other cytokines measured, apart from a
minor increase in IL-5 after Ply stimulation, no significant
changes in concentrations of IL-2, IL-4, and IL-10 were found
in PBMCs after stimulation by any antigen (data not shown).
In adenoidal MNCs, increases in concentrations of IFN-g and
IL-10 (figure 4D), but not in concentrations of IL-2, IL-4, IL-
5, and TNF-a (data not shown), compared with those noted
in unstimulated controls, were seen after stimulation by Ply
and F433 and, to a lesser extent, by CbpA. IFN-g and IL-10
concentrations in culture-positive patients tended to be higher
than those in culture-negative patients, although the differences
were not significant ( ) (figure 4D).P 1 .05
Induction of CD4 T cell proliferation by Ply and its asso-
ciation with TLR4. To study whether TLR2 or TLR4 is in-
volved in the induction of CD4 T cell proliferation by Ply,
Figure 2. A, Time course of CD4 T cell proliferation after stimulation with pneumolysin (Ply; 0.05 mg/mL), Ply toxoid (F433; 0.5 mg/mL), and choline-
binding protein A (CbpA; 1 mg/mL) in adenoidal (Ad) mononuclear cells (MNCs) (black symbols) and memory T cell–depleted (RO) cells (white symbols).
B, Cellular proliferation shown by carboxyfluorescein diacetate 5,6 succinimidyl ester (CFSE) staining at day 8 after stimulation with Ply, F433, and
CbpA in memory (CD45RO+) T cell–depleted Ad MNCs. Some proliferated cells have changed phenotype from RA+ to RA after stimulation. A and B,
Representative data from 1 of 6 experiments. C, CD4 T cell proliferation indices (mean + SD) after stimulation at day 8 in RO MNCs, compared
with Ad MNCs ( ). * , compared with medium control.np 10 P ! .01
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Figure 3. CD4 T cell proliferation indices (mean + SD) measured at
day 7 after stimulation with recombinant pneumolysin (Ply; 0.05 mg/mL),
Ply toxoid (F433; 0.5 mg/mL), choline-binding protein A (CbpA; 1 mg/mL),
and tetanus toxoid (TT; 1 Lf/mL) in peripheral blood mononuclear cells
(PBMCs) (A) and adenoidal mononuclear cells (MNCs) (B) from children
who were either culture positive ( ) or negative ( ) for pneu-np 12 np 26
mococci in nasal swab specimens. C, Cell proliferation in memory T cell–
depleted (RO) MNCs measured at day 8 after stimulation ( andnp 6
for culture-positive and culture-negative patients, respectively).np 12
* , compared with medium control; # , compared with culture-P ! .05 P ! .05
positive patients.
monoclonal antibodies to TLR4 (mTLR4) and TLR2 (mTLR2)
were preincubated with adenoidal MNCs or PBMCs before the
addition of Ply or F433. Figure 5 shows that mTLR4, but not
mTLR2 or isotype control, significantly but incompletely in-
hibited the CD4 T cell proliferation induced by Ply in both
types of cell culture. Similar inhibition by mTLR4—but not by
mTLR2—for F433-induced proliferation was also observed
(data not shown). Flow cytometric analysis showed that TLR4
was expressed on adherent cells (representing antigen-present-
ing cells [APCs], which accounted for 3%–6% and 15%–22%
of adenoidal MNCs and PBMCs, respectively) but not on CD4
T cells (data not shown).
Association of CD4 T cell proliferation and serum anti-
bodies to Ply and CbpA. To determine whether peripheral
CD4 T cell responses are correlated with serum antibody levels,
antigen-specific IgG and IgM antibodies to Ply and CbpA were
measured in serum. There was a moderate correlation between
CD4 T cell proliferation indices to Ply and F433 and anti-Ply
IgG antibody levels ( and , respectively;rp 0.31 rp 0.34 np
; ), but not anti-Ply IgM antibody levels ( ).38 P ! .05 P 1 .05
There was no correlation between CD4 T cell proliferation and
anti-CbpA IgG or IgM antibody levels ( ; ).P 1 .05 np 38
DISCUSSION
In the present study, we showed that the pneumococcal proteins
Ply and F433 and, to a lesser extent, CbpA induce CD4 T cell
proliferation in both PBMCs and adenoidal MNCs from chil-
dren. Upon stimulation by Ply or F433, the CD4 T cell pro-
liferation index in PBMCs was significantly higher in children
who were culture negative than in children who carried pneu-
mococci in their nasopharynx. To our knowledge, this is the
first report of T cell immunity to pneumococci in children and
of any association between natural T cell immunity and car-
riage. It suggests that natural CD4 T cell immunity to pneu-
mococcal protein antigens may modulate nasopharyngeal car-
riage, although it remains unclear whether this immunity can
prevent new colonization or help clear existing carriage. The
inverse relationship between a low CD4 T cell proliferation
index (in response to stimulation by Ply and F433) and carriage
found in PBMCs was not observed in adenoidal MNCs. One
possible explanation for this apparent difference is that, in chil-
dren who carried pneumococcus, antigen-specific (e.g., Ply)
memory CD4 T cells in the circulation (peripheral blood) may
migrate to the site of infection (nasopharynx) and become
sequestered in nearby lymphoid tissue, such as adenoids. Thus,
fewer antigen-specific memory T cells would remain in pe-
ripheral blood, resulting in diminished memory T cell responses
after stimulation in vitro. It has been previously reported that
during acute pneumococcal infection, there is a transient loss
of T cells, followed by the reappearance of these cells after
treatment and clinical improvement [19, 20]. However, the
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Figure 4. Association between CD4 T cell proliferation and production of interferon (IFN)–g and tumor necrosis factor (TNF)–a in peripheral blood
mononuclear cells (PBMCs) after stimulation with pneumolysin (Ply; 0.05 mg/mL) (A and C); and association of cytokine production in PBMCs (B) and
in adenoidal mononuclear cells (MNCs) (D) with patients’ carriage status. * , compared with culture-positive patients ( ). CbpA, choline-P ! .05 np 22
binding protein A; IL, interleukin; F433, pneumolysin toxoid.
Figure 5. Effect of monoclonal blocking antibodies to Toll-like receptor
(TLR)–2 (mTLR2; 20 mg/mL), TLR4 (mTLR4; 20 mg/mL), and isotype control
(20 mg/mL) on CD4 T cell proliferation induced by pneumolysin (Ply) in
adenoidal mononuclear cells (MNCs) and peripheral blood mononuclear
cells (PBMCs). * , compared with Ply stimulation alone. Mean +P ! .05
SD of 6 replicate experiments is shown.
children who carried pneumococcus in the present study did
not seem to have a loss of CD4+ T cells from peripheral blood,
because there was no difference in the percentage of CD4+ T
cells in PBMCs between these subjects and subjects who were
culture negative. In this context, colonized subjects did not
have acute invasive infection. There appeared to be differences
between CD4 T cell activation by Ply and CbpA, and our pre-
vious results showed that both Ply- and CbpA-specific anti-
bodies were associated with absence of carriage [10]. The rea-
sons why CbpA seems to induce mainly antibody-mediated
immunity and Ply induces both CD4 T cell– and antibody-
mediated immunity are currently unknown, but they could be
explained, in part, by the apparent activating effects of Ply on
antigen-presenting cells (authors’ unpublished observations).
CD45RA+ naive T cells predominated in PBMCs, whereas
CD45RO+ memory T cells predominated in adenoidal MNCs.
Using MACS cell separation, we assessed naive T cell prolif-
eration in the latter cell populations, which showed the same
pattern of lower responses to Ply and F433 in culture-positive
children (figure 3C) as seen in peripheral blood (figure 3A).
This observation raises the possibility that the differences in
PBMCs observed between culture-positive and culture-negative
children could be caused, at least in part, by differences in naive
cell responses to these antigens. The ability of Ply to induce
primary as well as memory CD4 T cell responses may be im-
portant for cellular immunity against pneumococcal carriage
and also may have implications for the use of this antigen in
pneumococcal vaccines intended for use in young children.
It is known that protein antigens generally induce T cell–
dependent antibody responses, and we have previously shown
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that human mucosal anti-CbpA and -Ply antibody production
is T cell dependent [21]. One could postulate that the observed
inverse association between CD4 T cell immunity to Ply and
carriage could reflect T cell support for production of anti-
bodies in vivo. However, only a weak correlation was found
between PBMC CD4 T cell proliferation and serum anti-Ply
IgG antibodies, and no association with anti-CbpA IgG or IgM
antibodies was found. This is compatible with the hypothesis
that CD4 T cell immunity may have an antibody-independent
effect against colonization. These results therefore concur with
results of recent studies in mice showing that CD4 T cell im-
munity may protect against pneumococcal colonization [13,
22] by an antibody-independent mechanism [11, 12].
Human naive and memory T cells can generally be identified
by the reciprocal expression of CD45RA or CD45RO isoforms
[23, 24]. Using CD45RO+ T cell–depleted MNCs, we showed
that Ply and F433 can induce CD4 T cell responses in both
memory and naive phenotypes (figure 2C), whereas CbpA in-
duced CD4 T cell responses of memory phenotypes only. The
phenotypically naive T cellular response to Ply and F433 is
interesting, because protein antigens usually require adjuvant
help to induce primary responses, perhaps through effects on
APCs (e.g., dendritic cells and macrophages) [25, 26], whereas
such need for APCs in memory T cell responses is not as strict
[27, 28]. Ply has been shown to induce activation of murine
macrophages to secrete inflammatory cytokines TNF-a and IL-
6 through TLR-4 [29]. In the present study, we showed that
CD4 T cell proliferation induced by Ply is partially inhibited
by antibody to TLR4, suggesting that Ply may induce T cell
proliferation in part through a TLR4-dependent mechanism.
Because no significant expression of TLR4 on CD4 T cells was
observed, and because dendritic cells and macrophages are
known to express TLR4 [30, 31], it is possible that the Ply-
induced CD4 T cell response is mediated through TLR4-de-
pendent activation of APCs.
We showed significant production of IFN-g but negligible
production of IL-4 in both PBMCs and adenoidal MNCs after
stimulation with Ply and F433, suggesting a Th1-type response.
In most infections, Th1-type responses have been associated
with strong cell-mediated inflammatory responses, which may
be favorable for pathogen elimination from the host [32]. It
has been reported that pneumococcal infections are associated
with increased trafficking of Th1 cells [19]. Mice lacking IFN-
g have been shown to be more susceptible to pneumococcal
infection [33], and administration of IFN-g could enhance
survival of mice after pneumococcal challenge [34]. However,
there appear to be differences in cytokine production between
PBMCs and adenoidal MNCs after antigen stimulation. Sig-
nificant induction of TNF-a was found in PBMCs but not in
adenoidal MNCs, whereas the reverse was noted for IL-10.
TNF-a is a proinflammatory cytokine that can promote pro-
tective immune responses against a variety of pathogens but
that may also cause inflammatory host injury under certain
conditions [35]. In contrast, IL-10 is a regulatory cytokine that
can suppress the proliferation and differentiation of Th1 cells
and, thus, can limit the potential immunopathology caused by
inflammatory responses [36]. It is possible that, in the mucosal
compartment exemplified by adenoidal MNCs, the production
and actions of the proinflammatory cytokines IFN-g and TNF-
a are tightly controlled by IL-10. In accordance with this, we
previously demonstrated inhibition by IL-10 of IFN-g pro-
duction by adenoidal cells [21]. CD4 T cell depletion from
PBMCs or adenoidal MNCs showed significant reduction
(75%–95%) in IFN-g and TNF-a or IL-10 production after
Ply or F433 stimulation (data not shown), suggesting that the
CD4 T cell is a major cellular source of these cytokines. The
induction of IFN-g and TNF-a in PBMCs by Ply in association
with T cell proliferation may play a role in protection against
pneumococcal carriage in children.
The results of the present study support the hypothesis that
CD4 T cellular immunity is involved in modulation of pneu-
mococcal colonization in humans. The induction of both
primary and memory CD4 T cell responses associated with
Th1-type cytokine production adds further information on the
nature of the immune responses to pneumococcal protein an-
tigens. The induction of CD4 T cell responses by Ply appears
to be regulated, in part, through TLR4 expressed by APCs.
Novel vaccines that include conserved protein antigens, such
as Ply or detoxified analogues, may induce significant CD4 T
cellular immunity and reduce colonization of multiple sero-
types of pneumococci.
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